| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Amicus Therapeutics Inc (NASDAQ: FOLD)
FOLD Technical Analysis
5
| As on 9th Jun 2023 FOLD SHARE Price closed @ 12.81 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 9.91 & Strong Buy for SHORT-TERM with Stoploss of 9.74 we also expect STOCK to react on Following IMPORTANT LEVELS. |
FOLDSHARE Price
| Open | 12.61 | Change | Price | % |
| High | 12.92 | 1 Day | 0.19 | 1.51 |
| Low | 12.52 | 1 Week | 1.55 | 13.77 |
| Close | 12.81 | 1 Month | 1.41 | 12.37 |
| Volume | 2396200 | 1 Year | 1.14 | 9.77 |
| 52 Week High 13.54 | 52 Week Low 6.23 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| FOLD Daily Charts |
FOLD Intraday Charts |
Whats New @ Bazaartrend |
FOLD Free Analysis |
|
|
FOLD Important Levels Intraday
| RESISTANCE | 13.58 |
| RESISTANCE | 13.33 |
| RESISTANCE | 13.18 |
| RESISTANCE | 13.03 |
| SUPPORT | 12.59 |
| SUPPORT | 12.44 |
| SUPPORT | 12.29 |
| SUPPORT | 12.04 |
FOLD Forecast April 2024
| 4th UP Forecast | 20.48 |
| 3rd UP Forecast | 18.02 |
| 2nd UP Forecast | 16.5 |
| 1st UP Forecast | 14.98 |
| 1st DOWN Forecast | 10.64 |
| 2nd DOWN Forecast | 9.12 |
| 3rd DOWN Forecast | 7.6 |
| 4th DOWN Forecast | 5.14 |
FOLD Weekly Forecast
| 4th UP Forecast | 15.05 |
| 3rd UP Forecast | 14.33 |
| 2nd UP Forecast | 13.89 |
| 1st UP Forecast | 13.44 |
| 1st DOWN Forecast | 12.18 |
| 2nd DOWN Forecast | 11.73 |
| 3rd DOWN Forecast | 11.29 |
| 4th DOWN Forecast | 10.57 |
FOLD Forecast2024
| 4th UP Forecast | 28.09 |
| 3rd UP Forecast | 23.19 |
| 2nd UP Forecast | 20.16 |
| 1st UP Forecast | 17.13 |
| 1st DOWN Forecast | 8.49 |
| 2nd DOWN Forecast | 5.46 |
| 3rd DOWN Forecast | 2.43 |
| 4th DOWN Forecast | -2.47 |
Amicus Therapeutics Inc ( NASDAQ USA Symbol : FOLD )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
FOLD Business Profile
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for people living with rare metabolic diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data; gene therapies for Fabry and Pompe diseases, as well as for various types of Batten diseases; enzyme replacement therapies for Pompe diseases; and CDKL5 deficiency disorder product candidates. The company also has additional gene therapies in active preclinical development, including gene therapies for mucopolysaccharidosis type IIIB, as well as a next generation program in mucopolysaccharidosis type IIIA. The company has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania. Address: 3675 Market Street, Philadelphia, PA, United States, 19104
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service